(Nature) – Hindering studies involving fetal tissue will impede the development of the alternatives intended to replace it, while slowing the search for new medicines. “This decision is about advancing science by investing in breakthrough technologies more capable of modeling … Read More
https://bioethics.com/archives/101428
